Y-Biologics Inc. (338840) Stock Forecast & Analysis
Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Y-Biologics Inc. (338840:KRX), powered by AI.
- Current Price
- ₩25,800
- P/E Ratio
- -59.2
- Market Cap
- 385.7B
- Sector
- Healthcare
What is the Y-Biologics Inc. stock price forecast?
Y-Biologics Inc. is currently trading at ₩25,800. View real-time AI analysis on Alpha Lenz.
What is Y-Biologics Inc. insider trading activity?
View the latest insider trading data for Y-Biologics Inc. on Alpha Lenz.
What is Y-Biologics Inc.'s P/E ratio?
Y-Biologics Inc.'s P/E ratio is -59.2.
Y-Biologics Inc.
KRX · 338840“Y-Biologics Inc. trades at a P/E of -59.2 (undervalued) with modest ROE of -30.8%.”
Ask for details →Company Overview
Y-Biologics Inc. is a biotechnology firm primarily engaged in developing antibody-based drugs and therapeutic solutions. The company focuses on innovative research and development to advance treatments for various diseases, including cancer and immune-related disorders. By leveraging cutting-edge technology in monoclonal antibody production, Y-Biologics aims to provide more effective and safer therapeutic options. The company's operations significantly impact the healthcare and pharmaceutical sectors, contributing to the evolving landscape of targeted medicine. Moreover, Y-Biologics Inc. holds a strategic position in the biotechnological market due to its robust pipeline of proprietary drug candidates and collaborative efforts with other industry players. Through its commitment to enhancing patient outcomes, Y-Biologics stands out as a notable entity within the life sciences arena, fostering healthcare advancements and exploring new frontiers in drug discovery and development.
Company Statistics
FY 2024Profile
Margins
Valuation
Growth (CAGR)
Returns
Financial Health
“Y-Biologics Inc. trades at a P/E of -59.2 (undervalued) with modest ROE of -30.8%.”
Ask for details →Frequently Asked Questions
Y-Biologics Inc. (ticker: 338840) is a company listed on KRX in the Healthcare sector (Biotechnology). Market cap is $385.7B.
The current price is ₩25,800 with a P/E ratio of -59.16x and P/B of 20.76x.
ROE is -30.85% and operating margin is -146.58%. Annual revenue is $5.8B.